Cargando…
Geroprotective effects of Alzheimer’s disease drug candidates
Geroprotectors are compounds that slow the biological aging process in model organisms and may therefore extend healthy lifespan in humans. It is hypothesized that they do so by preserving the more youthful function of multiple organ systems. However, this hypothesis has rarely been tested in any or...
Autores principales: | Kepchia, Devin, Currais, Antonio, Dargusch, Richard, Finley, Kim, Schubert, David, Maher, Pamela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906177/ https://www.ncbi.nlm.nih.gov/pubmed/33550278 http://dx.doi.org/10.18632/aging.202631 |
Ejemplares similares
-
The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice
por: Zahid, Saadia, et al.
Publicado: (2023) -
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism
por: Daugherty, Daniel, et al.
Publicado: (2017) -
Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer’s disease transgenic mice
por: Currais, Antonio, et al.
Publicado: (2014) -
Diverse proteins aggregate in mild cognitive impairment and Alzheimer’s disease brain
por: Kepchia, Devin, et al.
Publicado: (2020) -
Old age-associated phenotypic screening for Alzheimer's disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa
por: Fischer, Wolfgang, et al.
Publicado: (2018)